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1. Introduction 
To overcome donor shortage in organ transplantation, xenotransplantation using organs of 
genetically modified pigs has been actively investigated (Ekser and Cooper, 2010). Thus far, 
the development of genetically modified pigs has mainly focused on overcoming the 
immune rejection of the xenograft. The creation of knock-out pigs lacking the xenoantigen 
α1,3-galactosyltransferase (GalT-KO) (Dai et al., 2002; Kolber-Simonds et al., 2004; Lai et al., 
2002; Phelps et al., 2003) and transgenic pigs expressing complement regulatory factors 
(Fodor et al., 1994; Takahagi et al., 2005) has been successfully achieved. 
We have produced genetically modified pigs by the heterozygous knock-out of α1,3-
galactosyltransferase gene and the co-expression of two transgenes, human decay-
accelerating factor (hDAF) and N-acetylglucosaminyltransferase III (GnT-III) (Takahagi et 
al., 2005). Natural breeding of the heterozygous GalT-KO pigs could produce live 
homozygous GalT-KO pigs (Fujimura et al., 2008a; Fujimura et al., 2008b; Takahagi et al., 
2007) with the two transgenes. The three genetic modifications made to these pigs, namely, 
the GalT-KO plus expression of GnT-III and hDAF, should reduce rejection when their 
organs are used for discordant transplantation. More specifically, Galα1,3-Gal epitopes, 
which cause hyper-acute rejection, have been removed from the pig cells, thereby 
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reducing the antigenicity of the cells to human natural antibodies and suppressing the 
complement cascade reaction in the host. However, for the clinical application of 
xenotransplantation, it will be necessary to perform further genetic modifications in these 
pigs to overcome the various obstacles that exist in xenotransplantation (Ekser and 
Cooper, 2010; Klymiuk et al., 2010). 
One strategy for achieving a more advanced genetic modification of the pigs is the use of 
somatic cell nuclear transfer (SCNT). This approach should make it possible to create pigs 
with multiple genetic modifications based on the existing GalT-KO/transgenic pig. Using 
the SCNT technology shown in Fig. 1, it should be feasible to introduce novel genetic 
modifications through sequential cloning. This approach might be used for removal of non-
Gal antigens, controlling delayed xenograft rejection or cell-mediated immunity. In order to 
pursue such an approach, it is essential to know the reliability with which existing 
genetically modified pigs can be reproduced through somatic cell cloning technology. Here, 
we examined the feasibility of this strategy using three lines of GalT-KO pigs that had been 
created previously. We also describe the current efficiency of somatic cell cloning for 
generating genetically modified pigs for xenotransplantation research and discuss the 
prospects of applying this technology to achieve more sophisticated genetic modification of 
the pigs. 
 
 
 
 
Fig. 1. Multiple genetic modifications of pigs using sequential somatic cell cloning 
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2. Reproducing GalT-KO pigs by cloning 
In this study, we used somatic cell cloning to reproduce three types of GalT-KO pigs 
(DK3-1 male, DK3-2 female, DK3-9 female). These three types of pigs are all homozygous 
for the GalT-KO and were produced by intercrossing siblings derived from a mating of a 
heterozygous GalT-KO+hDAF+GnT-III pig to a wild-type pig (Table 1). DK3-1 and DK3-2 
express two transgenes, namely, hDAF and GnT-III (Takahagi et al., 2005). However, the 
integration patterns of the two transgenes (i.e., heterozygous or homozygous integration) 
were not examined. By contrast, DK3-9 is a homozygous GalT-KO pig with no integrated 
transgenes. 
 
Pig code number Gal-T KO* Transgenes** sex 
DK3-1 homozygous hDAF and GnT-III male 
DK3-2 homozygous hDAF and GnT-III female 
DK3-9 homozygous NIL female 
*α1,3-galactosyltransferase gene knock out 
** hDAF: decay-accelerating factor ; GnT-III: N-acetylglucosaminyltransferase III 
Table 1. Original Gal-T KO pigs cloned by somatic cell nuclear transfer 
3. Somatic cell cloning technology for reproduction of GalT-KO pigs 
3.1 Nuclear donor cells for somatic cell cloning: Preparation of preadipocytes and cell 
cycle synchronization 
Various types of primary cultured cells, such as fetal fibroblast cells, salivary gland 
progenitor cells and mesenchymal stem cells, have been used as the nuclear donor for 
somatic cell cloning (Faast et al., 2006; Kurome et al., 2008b; Matsunari et al., 2008b). For the 
cloning of GalT-KO pigs in this study, we used preadipocytes (Tomii et al., 2005; Tomii et 
al., 2009), which have consistently produced good results in somatic cell cloning in our 
laboratory. 
Primary cultures of preadipocytes were established as reported previously (Tomii et al., 
2005; Tomii et al., 2009) from the subcutaneous fat tissue of three homozygous Gal T-KO 
pigs at 6 months of age (Fig.2a, b). Subcutaneous fat tissue was collected by abdominal 
incision under general anesthesia and then washed with Dulbecco’s phosphate-buffered 
saline (PBS; Nissui Pharmaceutical, Tokyo, Japan) supplemented with 75 µg/ml penicillin G 
and 50 µg/ml streptomycin. Connective tissue surrounding the fat was removed using 
sterile scissors (Fig. 2b). Small pieces of fat tissue were then excised and incubated in 
Dulbecco’s Modified Eagle Medium (DMEM) with 2% (w/v) bovine serum albumin (BSA, 
Fraction V) and 0.1% (w/v) collagenase (Wako Pure Chemical, Osaka, Japan) for 1 h at 37˚C 
(Fig. 2c). Dissociated cells were collected by filtration through 100-µm nylon mesh (Falcon 
352360, Becton Dickinson, Franklin Lakes, NJ, USA). Following centrifugation at 150 g for 5 
min, only mature adipocytes that remained in suspension near the surface of the 
supernatant were collected (Fig. 2d), and these adipocytes were washed several times. The 
mature adipocytes (1×105) were then incubated in a T12.5 cell culture flask (growth area, 
12.5 cm2; Falcon 353018, Becton Dickinson) filled to the brim with DMEM containing 20% 
(v/v) fetal bovine serum (FBS; JRH Biosciences, Lenexa, KS, USA) and tightly capped. The 
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flask was inverted and incubated in a humidified atmosphere of 5% CO2 in air at 37˚C to 
encourage the adipocytes to attach to the inner ceiling of the flask (Fig. 2e). Following 
incubation for 7 days, morphological transition to a fibroblast-like shape, accompanied by a 
gradual decrease in the amount of cytoplasmic lipid droplets, was confirmed in cells 
attached to the flask’s inner ceiling surface. Following confirmation of firm cell attachment, 
the flask was again inverted, and routine culture methods for adherent cells were 
implemented (Fig. 2f). The medium was changed every three days, and after two passages, 
preadipocytes were resuspended in fresh media supplemented with 10% (v/v) dimethyl 
sulfoxide (CELLBANKER® 1, Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan) and 
were then frozen in liquid nitrogen. 
 
 
 
Fig. 2. Preparation of nuclear donor cells for somatic cell cloning from a GalT-KO pig: 
establishment of preadipocytes 
After thawing by routine procedures preadipocytes were used as nuclear donors following 
cell cycle synchronization by serum starvation according to the method described 
previously (Tomii et al., 2005; Tomii et al., 2009); that is, preadipocytes were cultured in 
DMEM supplemented with 20% FBS to sub-confluence followed by culture for 2 days in 
DMEM with 0.5% FBS. 
The ability of the obtained preadipocytes to re-differentiate into mature adipocytes was 
confirmed by the induction of differentiation in vitro (Tomii et al., 2005; Yagi et al., 2004). 
Sub-confluent preadipocytes were cultured for 4 days in DMEM supplemented with 20% 
(v/v) FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 5 μg/mL insulin and 0.25 μM 
dexamethasone to induce adipogenic differentiation. After replacing the medium with 
DMEM containing 20% FBS, the cells were further cultured for 6 days. To examine the lipid 
droplet accumulation, cells cultured for 10days after differentiation induction were fixed in 
10% (v/v) formalin and stained with Oil Red O for 20min. 
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(a) day-0  (b) day-1 
 
(c) day-3  (d) day-4 
 
(e) day-5  (f) day-7 
 
                                               (g) day-10                          (h) Oil Red O stained 
Fig. 3. Re-differentiation of preadipocytes established from the GalT-KO pig (DK3-2) 
Preadipocytes in sub-confluence before the induction of re-differentiation (a) and 1 to 10 
days (b-g) after re-differentiation induction (x40). Re-differentiated cells on day 10 after 
fixation and staining (x200). 
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3.2 Karyotyping of nuclear donor cells 
It is essential that the nuclei of the donor cells have a normal chromosomal constitution 
when creating somatic cell cloned animals. An examination of the cells showed that the 
normal chromosome number was present in 74% to 88% of the cells of the primary culture 
cell lines used in this study (Table 2, Fig. 4). 
  
 DK3-1 DK3-2 DK3-9 
Proportion of cells with 
normal chromosome number 
(2n=38) 
74% 
(37/50)* 
86% 
(43/50)* 
88% 
(44/50)* 
*Number of metaphase chromosome plates examined 
Table 2. Chromosome composition of the nuclear donor cells used for somatic cell cloning of 
the Gal-T KO pigs 
 
           (a) DK3-1             (b) DK3-2            (c) DK3-9 
Fig. 4. Normal chromosome numbers of the GalT-KO cells used for somatic cell cloning 
3.3 Preparation of recipient oocytes for somatic cell cloning 
Ovaries were recovered from gilts at a local slaughterhouse and transported to the 
laboratory in PBS containing 0.1% (w/v) polyvinyl alcohol (PVA), 75 µg/ml penicillin G, 
and 50 µg/ml streptomycin. Follicular fluid and cumulus-oocyte complexes (COCs) were 
aspirated from the follicles (diameter, 3 to 6 mm) using a 20-gauge needle attached to a 10-
ml disposable syringe. COCs with several layers of compact cumulus cells were selected and 
cultured in NCSU23 medium (Petters and Wells, 1993) supplemented with 0.6 mM cysteine, 
10 ng/ml EGF, 10 IU/ml eCG (ASKA Pharmaceutical, Tokyo, Japan) and hCG (ASKA 
Pharmaceutical), and 10% (v/v) porcine follicular fluid. Oocytes were cultured for 22 h with 
eCG and hCG in a humidified atmosphere of 5% CO2 in air at 38.5C and then for 18 to 20 h 
without these hormones in an atmosphere of 5% CO2, 5% O2, and 90% N2 at 38.5C. 
3.4 Somatic Cell Nuclear Transfer (SCNT) 
Nuclear transfer of preadipocytes was performed as described previously (Tomii et al., 
2005; Tomii et al., 2009). In vitro-matured oocytes with expanded cumulus cells were 
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treated with 1 mg/ml hyaluronidase and denuded of cumulus cells by pipetting. 
Enucleation was performed using a chemically assisted method developed by Yin et al. 
(Yin et al., 2002). Following culture in NCSU23 medium supplemented with 0.1 µg/ml 
demecolcine, 0.05 M sucrose (Nacalai Tesque, Kyoto, Japan), and 4 mg/ml BSA for 0.5 to 1 
h, mature oocytes that had the first polar body were enucleated by aspirating the polar 
body and adjacent cytoplasm using a beveled pipette (diameter, 30 µm) in 10 mM HEPES-
buffered Tyrode lactose medium containing 0.3% (w/v) polyvinylpyrrolidone (PVP), 0.1 
µg/ml demecolcine, 5 µg/ml cytochalasin B (CB), and 10% FBS (Fig. 5a). When a 
protrusion was observed on the surface of an oocyte, it was also removed with the polar 
body (Fig. 5b). Enucleation was confirmed by staining the cytoplasts with 5 µg/ml 
bisbenzimide (Hoechst 33342). 
 
 
(a) Enucleation 
 
 
(b) Protrusion 
 
Fig. 5. Enucleation of a porcine in vitro-matured oocyte: preparation of the recipient 
cytoplast for somatic cell cloning 
(a) Removal of the first polar body and adjacent cytoplasm by aspirating with a beveled 
pipette (1-5) 
(b) A protrusion (arrow head) visible on the surface of an oocyte was removed with the 
polar body (1-2) 
1 2 3 
4 5 
1 2
www.intechopen.com
 Xenotransplantation 
 
44
Preadipocytes were used as nuclear donors following cell cycle synchronization by serum 
starvation for 2 days. A single donor cell was inserted into the perivitelline space of an 
enucleated oocyte (Fig. 6). Donor cell-oocyte complexes were placed in a solution of 280 mM 
mannitol (Nacalai Tesque) (pH 7.2) containing 0.15 mM MgSO4, 0.01% (w/v) PVA, and 0.5 
mM HEPES and were held between two electrode needles (Fig. 7). Membrane fusion was 
induced with a somatic hybridizer (SSH-1; Shimadzu, Kyoto, Japan) by applying a single 
direct current (DC) pulse (200 V/mm, 20 μsec) and a pre- and post-pulse alternating current 
(AC) field of 5 V, 1 MHz for 5 sec, respectively. The reconstructed embryos were cultured in 
NCSU23 medium supplemented with 4 mg/ml BSA for 1 to 1.5 h, followed by electrical 
activation. Reconstructed embryos were then washed twice in an activation solution 
containing 280 mM mannitol, 0.05 mM CaCl2, 0.1 mM MgSO4, and 0.01% (w/v) PVA and 
were aligned between two wire electrodes (1.0 mm apart) of a fusion chamber slide filled 
with the activation solution. A single DC pulse of 150 V/mm was applied for 100 µsec using 
an electrical pulsing machine (ET-3; Fujihira Industry, Tokyo, Japan). Activated oocytes 
were treated with 5 µg/ml CB for 3 h to suppress extrusion of the pseudo-second polar 
body. 
 
 
(a) Nuclear donor cells 
 
 
(b) Insertion of donor cell 
 
Fig. 6. Insertion of nuclear donor cells into recipient cytoplast 
(a) Nuclear donor cells derived from the homozygous GalT-KO pig (DK3-1) 
(b) A single donor cell was inserted into the perivitelline space of an enucleated oocyte 
1 2 3 
www.intechopen.com
Cloning of Homozygous 1,3-Galactosyltransferase  
Gene Knock-Out Pigs by Somatic Cell Nuclear Transfer 
 
45 
 
Fig. 7. Fusion of a nuclear donor cell and recipient cytoplast 
An electric pulse was applied to a cell-oocyte complex using two electrodes (the chopstick 
method). 
3.5 Culture of SCNT embryos 
In vitro culture of SCNT embryos was performed in 20-µl droplets of PZM-5 (Functional 
Peptide Inc., Yamagata, Japan). The dish was maintained under a humidified atmosphere of 
5% CO2, 5% O2, and 90% N2 at 38.5C. Beyond the morula stage, embryos were cultured in 
PZM-5 supplemented with 10% FBS. Cleavage and blastocyst formation of the reconstructed 
embryos were monitored during culture for 7 days. On Day 7, the number of cells in the 
blastocysts was counted after fixation and staining. 
3.6 The effects of a histone deacetylase inhibitor on the development of SCNT 
embryos 
Some of the SCNT embryos produced here were cultured in the presence of a histone 
deacetylase inhibitor (HDACi) Scriptaid, and their subsequent development was examined. 
The SCNT embryos, which had been undergone electrical activation and cytochalasin B 
treatment, were cultured in the presence of 500 nM Scriptaid in PZM5 for 15–20 hours and 
were then transferred to normal medium for further culture. The effects of HDACi were 
assessed by the rate of SCNT embryos that developed into blastocysts and the cell numbers 
in the blastocysts obtained. 
3.7 Embryo transfer 
Crossbred (Large White / Landrace × Duroc) prepubertal gilts weighing from 100 to 105 kg 
were used as recipients of the SCNT embryos. Gilts were treated with a single intramuscular 
injection of 1000 IU eCG (ASKA Pharmaceutical) to induce estrus. Ovulation was induced 
by an intramuscular injection of 1500 IU hCG (Kawasakimitaka Pharmaceutical, Kanagawa, 
Japan) given 68 h after the injection of eCG. Cloned embryos cultured for 1 or 2 days were 
surgically transferred into the oviducts of recipients approximately 51-54 h after hCG 
injection. Embryos cultured for 6 days were transferred at the blastocyst stage to the uterine 
horns of the recipients approximately 146 - 148 hr after hCG injection. 
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3.8 Analysis of cloned piglets 
Homozygous GalT gene knock out in the cloned pigs was confirmed by PCR as described 
previously (Fujimura et al., 2008a; Fujimura et al., 2008b; Takahagi et al., 2005). Briefly, tail 
chips derived from the cloned pigs and a control non-transgenic pig were lysed overnight at 
55°C in a lysis solution (10 mM Tris, pH 8.0, 1 mM EDTA, 100 mM NaCl, 0.5 % SDS, and 100 
µg/mL Proteinase K). The lysates were extracted with phenol-chloroform followed by 
ethanol precipitation. The genomic DNA was resolved in TE buffer. 
The primer sets used were the same as those described in previous reports (Fujimura et 
al., 2008a; Fujimura et al., 2008b; Takahagi et al., 2005). In the case of a targeted allele in 
which the GalT gene has been replaced with a marker gene (hygromycin-resistance gene), 
a DNA fragment of approximately 10 kb was amplified; however, in the case of the wild-
type allele, a DNA fragment of approximately 7.6 kb was amplified. Amplification was 
performed on genomic DNA using the Expand Long Template PCR System (Roche; the 
forward primer was 5’-AGAGGTCGTGACCATAACCAGAT-3’, and the reverse primer 
was 5’-AGCCCATCGTGCTGAACATCAAGTC-3’). After an initial denaturation step of 
94°C for 2 min, PCR amplification was performed for 30 cycles of 94°C for 15 sec, 65°C for 
30 sec and 68°C for 10 min with a 20-sec extension per cycle, and this was followed by 
incubation at 68 C for 7 min. Amplification products were analyzed by 1 % agarose gel 
electrophoresis. 
4. In vitro development of cloned embryos derived from the GalT-KO pigs: An 
index for successful pig cloning 
In vitro culture can provide an approximate estimate of the competence of SCNT embryos to 
develop into live cloned offspring. Since transcription from the embryonic genome starts 
around the 4-cell stage in porcine embryos, the early cleavage stages may be able to progress 
regardless of the existence of genomic aberrations. We found that the cleavage rate to the 2- 
to 8-cell stage in cloned embryos reconstructed from cells with numerical chromosome 
anomalies was similar to that of cloned embryos derived from normal cells (unpublished 
data). Although in vitro development into blastocysts does not guarantee the normalcy of 
the SCNT embryos, the ability to reach this developmental stage is nevertheless a reasonable 
indicator of whether cloned offspring can be obtained from the SCNT embryos. This raises 
the question of what rate of development of SCNT embryos into blastocysts is necessary to 
ensure that cloned pigs can be obtained. This question is difficult to answer as the culture 
conditions for embryos differ among laboratories. However, in our experience, when the 
developmental rate of cloned embryos produced using a given type of nuclear donor cell 
was over 30%, cloned pigs could almost always be obtained. With our porcine somatic cell 
cloning procedures, the in vitro developmental rate of the SCNT embryos into blastocysts 
exceeds 50%, and in such cases, the pregnancy rate of the recipients after transfer of the 
cloned embryo is almost 100%. 
The in vitro development of the SCNT embryos is significantly improved by culture in the 
presence of a histone deacetylase inhibitor (HDACi), e.g., trichostatin A (TSA) and Scriptaid 
(Zhao et al., 2010). This improvement can be explained by the activation of transcription of 
genes involved in development, which results from histone hyperacetylation in the 
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chromosomes of the cloned embryos. Table 3 summarizes the in vitro development of SCNT 
embryos created from GalT-KO cells. The blastocyst formation rate in the SCNT embryos 
derived from GalT-KO pig cells (DK3-1) was significantly improved (51.4 vs. 77.1%, P<0.05) 
by Scriptaid treatment. As shown in Fig. 8, the morphology of the cloned blastocysts treated 
with HDACi was better than that of untreated blastocysts, and the number of constituent 
cells was high. 
 
Scriptaid 
treatment 
No. of NT 
embryos 
cultured 
Embryonic development (%) Average cell number 
in blastocysts 
(mean  ±SEM) Cleaved Blastocysts 
+ 35 27 (77.1)a 27 (77.1)a 70.9 ±6.5a 
- 37 33 (89.2)a 19 (51.4)b 62.2 ±5.3a 
a, bValues with different superscripts in the same column differ significantly 
Table 3.  In vitro development of porcine SCNT embryos treated with Scriptaid 
 
            (a) Scriptaid(+)         (b) Scriptaid(-) 
Fig. 8. Morphology of cloned porcine blastocysts treated with Scriptaid 
5. Creation of cloned pigs from GalT-KO cells 
The results of transfer experiments with the cloned embryos are presented in Table 4. 
Transfer of the 547 cloned embryos reconstructed with the donor cells from DK3-1 into 6 
recipients gave rise to 6 pregnancies (100%). Although 2 miscarried at 30 and 21 days of 
gestation, 2 recipients farrowed 10 piglets, including 2 stillborn piglets. From 2 other 
recipients, a total of 7 live full-term piglets were obtained by Caesarian section. The overall 
production efficiency of the cloned piglets was 3.1% from the recipients that farrowed or 
received a Caesarian section (17/547). Cloning efficiency of GalT-KO pigs in these 
experiments was comparable to that of non-KO pigs that we had reported previously 
(Kurome et al., 2006; Matsunari et al., 2008b). 
As shown in fig., the DK3-1 cloned piglets were apparently healthy, though they were all 
sacrificed for analysis within 72 h. The average body weight and crown-rump length of the 
cloned piglets were 822.9 +/- 47.3 g and 24.7 +/- 0.6 cm, respectively (Table 5). The birth 
weights of the cloned pigs were much less than those of non-transgenic pigs with a common 
genetic back ground in our experimental farm (1.0 - 1.5 kg). 
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*Obtained by Caesarian section 
**Within the piglets or full-term fetuses obtained 
***Cloned embryos were produced from donor cells that were transported internationally 
Table 4. The effects of Scriptaid treatment on the in vivo development of porcine SCNT 
embryos derived from Gal-T KO cells 
 
Fig. 9. Cloned offspring produced by SCNT of the homozygous GalT-KO pig cells co-
expressing hDAF and GnT-III (DK3-1) 
We also conducted an experiment in which cloned embryos, created using the cells from 
DK3-1, were treated with the HDACi Scriptaid and then transferred to recipients (Table 4). 
A total of 635 cloned embryos were transplanted into 5 recipients, all of which became 
pregnant (100%). By natural birth or full-term Caesarian section, 13 offspring were obtained 
from the recipients (5 were stillborn). The efficiency of producing offspring was 2.0% 
(13/635), indicating that HDACi treatment did not provide a marked improvement. 
However, it is notable that the six pregnant recipients did not have miscarriages in the 
experiment that used the HDACi treatment. 
The body weight and length of the cloned piglets obtained from the 3 lines of GalT-KO cells 
are presented in Table 5. 
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DK3-1  
Scriptaid (-) 
DK3-1  
Scriptaid (+) 
DK3-2  
Scriptaid (-) 
DK3-9  
Scriptaid (+) 
Weight  
(g) 
Length
 (cm) 
Weight 
(g) 
Length
 (cm) 
Weight
 (g) 
Length
 (cm) 
Weight 
(g) 
Length  
(cm) 
780 23 900 28 720* 23 1000 25 
820 24 840* 25 480* 19 1000 26 
820* 24 600* 23   1100 27 
900 25 700* 25   900 25 
1120 29 1500 27   700 23 
580 23 1200 28   500 20 
560 22 900 23   380 19 
730 25 800 24   
1060* 27 900 25  
700 22 600 22.5 
700 23 600 24 
600 22 700* 26 
920 25 700 24 
1100 29 
900 25 
1120 29 
580 23 
*stillborn piglets 
 
Groups Average  
body weight (g) 
(mean± SEM) 
Average  
body length (cm) 
(mean± SEM) 
DK3-1 / Scriptaid (-) 822.9± 47.3 24.7± 0.6 
DK3-1 / Scriptaid (+) 841.5± 72.0 25.0± 0.5 
DK3-2 / Scriptaid (-) 600.0** 21** 
DK3-9 / Scriptaid (+) 797.1± 104.2 23.6± 1.2 
** SEM was not given due to limited sample numbers 
Table 5. Body weight and length of the cloned piglets derived from the three types of the 
GalT-KO pigs 
When 176 cloned embryos derived from DK3-2 were transferred into 2 recipients, both 
became pregnant, and 2 stillborn piglets were delivered (Table 4). The body weights and 
crown-rump lengths of these piglets were also much less than those of the normal piglets: 
480 g compared with 720 g and 19 cm compared with 23 cm, respectively (Table 5). These 
stillborn piglets were delivered 2 days later than the expected date of farrowing. This delay 
may explain the weak DNA amplification signal obtained by PCR (Fig. 10). 
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Homozygous knock-out of the GalT gene was confirmed in all of the cloned pigs by PCR 
(Fujimura et al., 2008a; Fujimura et al., 2008b; Takahagi et al., 2005) (Fig. 10). 
Transmission of the two transgenes, i.e., hDAF and GnT-III, was also confirmed in the 
cloned offspring. In the present study, we did not examine expression of these transgenes. 
However, faithful expression of transgenes in the cloned offspring produced by SCNT of a 
polytransgenic pig has been demonstrated in our previous studies (Fujimura et al., 2008a; 
Fujimura et al., 2008b; Takahagi et al., 2005). The influence of epigenetic modification on 
gene expression in cloned pigs needs to be investigated. 
 
 
 
Fig. 10. PCR and PCR–Southern analysis of cloned pigs derived from homozygous GalT-KO 
pig somatic cells 
Cloned pigs were produced from cells derived from DK3-9 (Table 4). DK3-9 is a GalT-KO 
homozygote and has no other genetic modification or transgene integration. The cloned 
embryos were treated with 500 nM Scriptaid for 15–20 hours. When 377 SCNT embryos 
were transplanted at the early cleavage stages (day 1 to 3), all 4 recipients became pregnant, 
and one sow farrowed seven live offspring. The average body weight and crown-rump 
length of the cloned piglets derived from the DK3-9 cells were 797.1+/- 104.2 g and 23.6 +/- 
1.2 cm (Table 5). The other recipients had miscarriages. In the cloning experiments with 
DK3-9 cells, several miscarriages occurred, although the SCNT embryos had been treated 
with HDACi Scriptaid. This result is in contrast to the results of the cloning of DK3-1. It may 
be pertinent that the experiments with DK3-9 were performed during one of the hottest 
summers recorded in Japan, and this may have affected the recipients’ pregnancies; further 
investigation will be necessary to identify the causes of the difference in experimental 
outcomes. Most of the cloned offspring with a normal range body weight were healthy and 
grew normally (Figs. 11, 12). 
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Fig. 11. Growth of the cloned pigs derived from the GalT-KO cells (DK3-9) 
 
Fig. 12. Live offspring of a GalT-KO pig (DK3-9) produced by somatic cell cloning 
The GalT-KO pig (DK3-9) cells that we created were transported by air from Japan to 
Germany and used to produce cloned pigs. As shown in Table 4, 214 cloned embryos were 
produced and transferred into 2 recipient sows. Both recipients became pregnant, and one 
cloned offspring was produced. 
6. The prospect of the development of genetically modified pigs and the 
development of “rainbow pigs” 
To bring xenotransplantation into clinical application, it is essential to overcome xenograft 
rejections, such as hyperacute rejection, delayed xenograft rejection, and cellular rejection 
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(Ekser and Cooper, 2010). Genetic modification of pigs by technologies based on SCNT 
would be the most promising approach to solve these issues. Furthermore, the advantage of 
SCNT is that additional genetic modification can be achieved based on the analysis of 
phenotypic expression of the resulting genetically modified pigs (Fig. 1). Genetically 
modified pigs so far developed as xenotransplantation donors including ours (Fujimura et 
al., 2008a; Fujimura et al., 2008b; Takahagi et al., 2005) will be further improved. With 
multiple gene modifications in pigs, the feasibility of serial somatic cell cloning (multi-
generational cloning) would have important implications. In this regard, we have 
successfully produced the 4th generation of cloned pigs by serial cloning (Kurome et al., 
2008a; Matsunari et al., 2008a). We have developed a process for multi-generational cloning 
of pigs, that is, a means of proceeding from the first clone generation (G1) to the second (G2) 
and then to the third generation (G3), and the efficiency of producing cloned pigs 
throughout this process was almost constant (Kurome et al., 2008a; Matsunari et al., 2008a). 
Notably, the cloned offspring did not show any shortening of their telomeres (Kurome et al., 
2008a) and grew normally. Our results indicate that serial cloning is a feasible option for 
production of specifically designed pigs with multiple genetic modifications. 
In this study, we investigated the feasibility of cloning the GalT-KO pigs by focusing on the 
introduction of multiple genetic modifications into pigs. The application of somatic cell 
cloning in xenotransplantation research is not limited to genetic modifications. Somatic cell 
cloning could also be used for reproducing large numbers of pigs with a preexisting genetic 
modification for use in organ transplantation experiments in primates and for other 
preclinical research (Kuwaki et al., 2005; Yamada et al., 2005). We have already started an 
organ transplantation experiment using the cloned GalT-KO pigs (unpublished). 
Additionally, as already discussed, while it is difficult to transport genetically modified 
pigs, it is a comparatively simple matter to transport cells from the pigs by air to overseas. 
Development of genetically modified pigs has been attempted in several countries, 
including Australia, Britain, Germany, Japan, South Korea and the USA, with the aim of 
applying such animals in xenotransplantation. To realize their potential for clinical 
applications, it will be necessary to create pigs that incorporate all of the desired genetic 
modifications. We shall continue our pursuit of the ultimate goal of producing "rainbow" 
pigs—cloned pigs covering every possible genetic modification of medical interest. 
7. Conclusion 
In conclusion, the data presented in this chapter demonstrate that homozygous GalT-KO 
pigs can be efficiently reproduced by SCNT; hence, cloning technology is suggested to be a 
feasible option for proliferation of the genetically modified pigs. As part of the process of 
developing organ donors for xenotransplantation, somatic cell cloning provides an efficient 
and superior technology with high reliability and reproducibility for creating and 
reproducing pigs with multiple genetic modifications. 
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(Inventory of Human Xenotransplantation Practices - IXA and HUG in collaboration with WHO). In addition, a
new clinical trial was approved by the government, and resumed the porcine islet transplantation research in
New Zealand two years ago.
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